Physician profile
Amay Parikh
NPI 1740464924
$7,744.98
in general payments reported to CMS, 2019-2025
17 companies · $6,541 in 2025
The $6,541 reported for 2025 was more than what 93% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $603 · 2020: $105 · 2021: $125 · 2022: $154 · 2023: $85.17 · 2024: $133 · 2025: $6,541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,520 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500 · Food and Beverage: $613 · Travel and Lodging: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,520.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
| Food and Beverage | $612.51 |
| Travel and Lodging | $126.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Incorporated | $4,646.00 | 2025 | Blue Rhino |
| Coaptech, INC. | $1,682.28 | 2025 | Puma System, Puma System |
| Baxter Healthcare | $350.00 | 2019 | |
| Cook Medical LLC | $212.45 | 2025 | Blue Rhino |
| Ceribell, INC. | $171.79 | 2022-2023 | Ceribell Rapid Response Eeg |
| Abiomed | $132.61 | 2024 | Impella |
| Genentech USA, INC. | $128.94 | 2019 | |
| Alexion Pharmaceuticals, INC. | $125.00 | 2021 | |
| Portola Pharmaceuticals, LLC | $124.05 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $84.22 | 2020 | |
| Chiesi USA, INC. | $23.45 | 2023 | Cleviprex |
| Boston Scientific Corporation | $22.82 | 2023 | Exalt Model D |
| Teleflex LLC | $20.79 | 2022 | |
| Csl Behring | $20.58 | 2020 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amay Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.